Genesis Regenerative

Regenerative Protein Array (RPA) represents a groundbreaking advancement in the science of tissue healing. RPA is a sophisticated array of proteins, growth factors, and cytokines derived from placental tissue. This innovative approach is based on the understanding that the therapeutic power of regenerative medicine lies not in the direct transformation of injected stem cells into target tissues, but rather in their ability to modify the surrounding cellular environment through key biological messages.

Genesis Regenerative was born of a strategic partnership between two leading medical companies’ executive teams in 2023. NOVO Bio Alliance’s and DG Medical’s executive teams have over 100 years of experience in the medical device, nutraceutical, and regenerative medicine arena, and over 50 years of experience in the healthcare data management industry. Together, they created a powerhouse company that is highly skilled in launching cutting-edge medical therapies, building clinician networks, and providing educational tools to clinicians and patients alike.